Concepedia

Shawn Zinnen

SZ

Statistics

Publications

15

Citations

2.3K

H-Index

14

Active since

1993

Affiliations

MBC Pharma (United States)(Current)

University of Colorado Boulder

San Diego State University

University of Turku

Nivalis Therapeutics (United States)

Shawn Zinnen is an author at MBC Pharma (United States) specializing in life sciences, molecular biology, and biochemistry.

ORCID

Publications per year

1993–2018

15

Publications

15

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard et al. · Nature Biotechnology · 2005 · 1.2K citations

, , +12

Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1

Jikui Shen, Rebecca Samul, R L Silva et al. · Gene Therapy · 2005 · 306 citations

, , +14

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†

Karin S. Blanchard, Lucinda Shaw, Kristi Jensen et al. · Hepatology · 2005 · 291 citations · Full text

, , +17

Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase.

Jui-Yi Hsieh, Shawn Zinnen, Paul Modrich · Journal of Biological Chemistry · 1993 · 161 citations · Full text

, , +16

Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase.

Shawn Zinnen, Jui-Yi Hsieh, Paul Modrich · Journal of Biological Chemistry · 1994 · 73 citations · Full text

, , +13

1–5 of 15